Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic
In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined...
Uloženo v:
| Vydáno v: | Scientific reports Ročník 13; číslo 1; s. 712 - 5 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
Nature Publishing Group UK
13.01.2023
Nature Publishing Group Nature Portfolio |
| Témata: | |
| ISSN: | 2045-2322, 2045-2322 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital’s Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%;
p
< 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases. |
|---|---|
| AbstractList | In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital's Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases.In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital's Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases. In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital’s Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases. In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital’s Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases. In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital’s Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases. Abstract In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated the proportion of reinfections among all the cases of SARS-CoV-2 infection from March 10, 2020 until March 10, 2022. Reinfection was defined as the appearance of new symptoms that on medical evaluation were suggestive of COVID-19 and confirmed by a positive RT-PCR. Symptoms had to occur more than 90 days after the previous infection. These 2 years were divided into time periods based on the different variants of concern (VOC) in the city of São Paulo. There were 37,729 medical consultations due to COVID-19 at the hospital’s Health Workers Services; and 25,750 RT-PCR assays were performed, of which 23% (n = 5865) were positive. Reinfection by SARS-CoV-2 was identified in 5% (n = 284) of symptomatic cases. Most cases of reinfection occurred during the Omicron period (n = 251; 88%), representing a significant increase on the SARS-CoV-2 reinfection rate before and during the Omicron variant period (0.8% vs. 4.3%; p < 0.001). The mean interval between SARS-CoV-2 infections was 429 days (ranged from 122 to 674). The Omicron variant spread faster than Gamma and Delta variant. All SARS-CoV-2 reinfections were mild cases. |
| ArticleNumber | 712 |
| Author | Tomazini, Francis M. de Faria, Elizabeth Luna-Muschi, Alessandra Levin, Anna S. Lazari, Carolina dos Santos Tavares, Bruno M. Guedes, Ana Rubia Barboza, Antonio dos Santos Oliveira, Maura S. Leme, Mariana Deckers Maia, Fernando Liebhart Costa, Silvia Figueiredo Montal, Amanda C. |
| Author_xml | – sequence: 1 givenname: Ana Rubia orcidid: 0000-0002-6358-2912 surname: Guedes fullname: Guedes, Ana Rubia organization: Infection Control Department, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo – sequence: 2 givenname: Maura S. surname: Oliveira fullname: Oliveira, Maura S. organization: Infection Control Department, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo – sequence: 3 givenname: Bruno M. surname: Tavares fullname: Tavares, Bruno M. organization: Infection Control Department, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo – sequence: 4 givenname: Alessandra surname: Luna-Muschi fullname: Luna-Muschi, Alessandra organization: Instituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo, Department of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo – sequence: 5 givenname: Carolina dos Santos surname: Lazari fullname: Lazari, Carolina dos Santos organization: Central Laboratory Division, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo – sequence: 6 givenname: Amanda C. surname: Montal fullname: Montal, Amanda C. organization: Central Administration of Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo – sequence: 7 givenname: Elizabeth surname: de Faria fullname: de Faria, Elizabeth organization: Central Administration of Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo – sequence: 8 givenname: Fernando Liebhart surname: Maia fullname: Maia, Fernando Liebhart organization: Healthcare Worker Health Services, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo – sequence: 9 givenname: Antonio dos Santos surname: Barboza fullname: Barboza, Antonio dos Santos organization: Healthcare Worker Health Services, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo – sequence: 10 givenname: Mariana Deckers surname: Leme fullname: Leme, Mariana Deckers organization: Healthcare Worker Health Services, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo – sequence: 11 givenname: Francis M. surname: Tomazini fullname: Tomazini, Francis M. organization: Central Administration of Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo – sequence: 12 givenname: Silvia Figueiredo surname: Costa fullname: Costa, Silvia Figueiredo email: silviacosta@usp.br organization: Instituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo, Department of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo – sequence: 13 givenname: Anna S. orcidid: 0000-0003-2427-8368 surname: Levin fullname: Levin, Anna S. organization: Infection Control Department, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, Instituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo, Department of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36639411$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Ut1uFCEYnZga-2NfwAtD4o03o8AwA9yYmK3VTZo0MWriFWHgY5d1FlaYrenb-Cw-mexOrW0vyg0fcM7hwHeOq4MQA1TVC4LfENyIt5mRVooaU1rTVmJRd0-qI4pZW9OG0oM79WF1mvMKl9FSyYh8Vh02XdeUkhxV3z-DDw7M6GNASY-AfEAambiMaUTRoSXoYVwanQD9iukHpIziFSRE__y-Br1bOTQuAc0uv83PaiLRRgcLa2-eV0-dHjKc3swn1dfzD19mn-qLy4_z2fuL2rQMjzUI2VjSU8Z6YQzmrhGtI1rqjlhMGTYYeC-xZY5rRx1I0nHSSWscZWBb15xU80nXRr1Sm-TXOl2rqL3ab8S0UDqN3gyghOGkxbIDazUDh6Ug1PbGCMd5TwUUrXeT1mbbr8EaCGPSwz3R-yfBL9UiXikpGs5bUgRe3wik-HMLeVRrnw0Mgw4Qt1lR3rWcl4bxAn31ALqK2xTKV-1RlEnZyIJ6edfRrZV_HSwAOgFMijkncLcQgtUuKWpKiipJUfukqK6QxAOS8aPeZaC8yg-PU5uJmss9YQHpv-1HWH8Bp-_SEg |
| CitedBy_id | crossref_primary_10_1002_hsr2_71254 crossref_primary_10_1016_j_heliyon_2024_e26619 crossref_primary_10_3390_v15102100 crossref_primary_10_1590_s1678_9946202567033 crossref_primary_10_1186_s44263_025_00189_z crossref_primary_10_3390_jpm13101474 crossref_primary_10_1038_d41586_023_01371_9 crossref_primary_10_3389_fpubh_2023_1290402 crossref_primary_10_3390_ijerph20043335 crossref_primary_10_3389_fimmu_2024_1344086 crossref_primary_10_3389_fpubh_2025_1521658 crossref_primary_10_2196_63190 crossref_primary_10_1186_s12879_024_09225_z crossref_primary_10_1093_bfgp_elad051 crossref_primary_10_1186_s12879_024_09221_3 crossref_primary_10_3390_healthcare11081077 crossref_primary_10_7189_jogh_13_06051 crossref_primary_10_3390_v15071551 crossref_primary_10_7759_cureus_61470 crossref_primary_10_1002_pcn5_70017 crossref_primary_10_3390_vaccines12060682 crossref_primary_10_3389_fdata_2023_1355080 crossref_primary_10_1038_s41598_025_89472_5 crossref_primary_10_1142_S021833902550010X crossref_primary_10_1007_s13762_024_05665_x crossref_primary_10_1371_journal_pone_0303813 crossref_primary_10_3390_computation13050113 crossref_primary_10_1001_jamanetworkopen_2023_9840 crossref_primary_10_1002_hsr2_2016 crossref_primary_10_3390_jcm12113861 crossref_primary_10_1007_s42770_024_01467_y crossref_primary_10_1177_21650799231212898 crossref_primary_10_1186_s12884_024_06657_y crossref_primary_10_3389_fpubh_2023_1321283 crossref_primary_10_1017_S0950268824000487 crossref_primary_10_3390_v15040967 crossref_primary_10_3390_ijms25158155 crossref_primary_10_3390_vaccines11030626 crossref_primary_10_1038_s41598_023_41841_8 crossref_primary_10_1080_23744235_2024_2367112 crossref_primary_10_3390_vaccines13080815 |
| Cites_doi | 10.1016/S1473-3099(22)00069-X 10.1016/S0140-6736(21)00183-5 10.1016/S0140-6736(21)00575-4 10.1056/NEJMoa2118946 10.1016/j.cmi.2021.07.030 10.1016/j.cll.2021.10.004 10.1111/eci.13520 10.1093/cid/ciaa1845 10.2807/1560-7917.ES.2020.25.3.20000459- 10.1016/j.envres.2022.112911 10.1093/cid/ciab952 10.15585/mmwr.mm7115e2 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023 2023. The Author(s). The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U 7X8 5PM DOA |
| DOI | 10.1038/s41598-022-25908-6 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection PML(ProQuest Medical Library) Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2045-2322 |
| EndPage | 5 |
| ExternalDocumentID | oai_doaj_org_article_8c715096edda4ef09812dbcc8f77b28e PMC9837751 36639411 10_1038_s41598_022_25908_6 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Brazil |
| GeographicLocations_xml | – name: Brazil |
| GrantInformation_xml | – fundername: Itaú Unibanco “Todos pela saúde” program. – fundername: ; |
| GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFFHD AFPKN CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PKEHL PQEST PQUKI Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c540t-e893d1b244b8cc07f385f1a9a61d0240c0e7b90d4f7af2fe9167169dcf24ed5f3 |
| IEDL.DBID | M2P |
| ISICitedReferencesCount | 50 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000968670400015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2045-2322 |
| IngestDate | Tue Oct 14 18:42:11 EDT 2025 Tue Nov 04 02:06:31 EST 2025 Thu Oct 02 11:27:30 EDT 2025 Tue Oct 07 07:46:51 EDT 2025 Thu Apr 03 07:02:41 EDT 2025 Sat Nov 29 02:07:50 EST 2025 Tue Nov 18 22:04:21 EST 2025 Fri Feb 21 02:39:37 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2023. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c540t-e893d1b244b8cc07f385f1a9a61d0240c0e7b90d4f7af2fe9167169dcf24ed5f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-2427-8368 0000-0002-6358-2912 |
| OpenAccessLink | https://www.proquest.com/docview/2765249939?pq-origsite=%requestingapplication% |
| PMID | 36639411 |
| PQID | 2765249939 |
| PQPubID | 2041939 |
| PageCount | 5 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_8c715096edda4ef09812dbcc8f77b28e pubmedcentral_primary_oai_pubmedcentral_nih_gov_9837751 proquest_miscellaneous_2765772597 proquest_journals_2765249939 pubmed_primary_36639411 crossref_primary_10_1038_s41598_022_25908_6 crossref_citationtrail_10_1038_s41598_022_25908_6 springer_journals_10_1038_s41598_022_25908_6 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-01-13 |
| PublicationDateYYYYMMDD | 2023-01-13 |
| PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-13 day: 13 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Scientific reports |
| PublicationTitleAbbrev | Sci Rep |
| PublicationTitleAlternate | Sci Rep |
| PublicationYear | 2023 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | Costa, Giavina-Bianchi, Buss (CR7) 2021; 73 CR2 Akinbami, Biggerstaff, Chan, McGibbon, Pathela, Petersen (CR4) 2022; 75 Sabino, Buss, Carvalho, Prete, Crispim, Fraiji, Pereira, Parag, Peixoto, Kraemer, Oikawa, Salomon, Cucunuba, Castro, Santos, Nascimento, Pereira, Ferguson, Pybus, Kucharski, Busch, Dye, Faria (CR6) 2021; 397 Cohen, Kleynhans, von Gottberg (CR10) 2022; 22 Plumb, Feldstein, Barkley (CR5) 2022; 71 Slezak, Bruxvoort, Fischer, Broder, Ackerson, Tartof (CR8) 2021; 27 CR15 Pilz, Theiler-Schwetz, Trummer, Krause, Ioannidis (CR3) 2022; 8 CR13 Corman, Landt, Kaiser (CR14) 2020; 25 Zuiani, Wesemann (CR1) 2022; 42 Hansen, Michlmayr, Gubbels, Mølbak, Ethelberg (CR11) 2021; 397 Goldberg, Mandel, Bar-On (CR12) 2022; 386 Pilz, Chakeri, Ioannidis (CR9) 2021; 51 A Zuiani (25908_CR1) 2022; 42 ID Plumb (25908_CR5) 2022; 71 S Pilz (25908_CR9) 2021; 51 C Cohen (25908_CR10) 2022; 22 LJ Akinbami (25908_CR4) 2022; 75 J Slezak (25908_CR8) 2021; 27 25908_CR13 S Pilz (25908_CR3) 2022; 8 25908_CR2 25908_CR15 SF Costa (25908_CR7) 2021; 73 CH Hansen (25908_CR11) 2021; 397 EC Sabino (25908_CR6) 2021; 397 VM Corman (25908_CR14) 2020; 25 Y Goldberg (25908_CR12) 2022; 386 |
| References_xml | – volume: 22 start-page: 821 issue: 6 year: 2022 end-page: 834 ident: CR10 article-title: SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: Results of the PHIRST-C cohort study, South Africa, 2020–21 publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(22)00069-X – volume: 397 start-page: 452 year: 2021 end-page: 455 ident: CR6 article-title: Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence publication-title: Lancet doi: 10.1016/S0140-6736(21)00183-5 – volume: 397 start-page: 1204 issue: 10280 year: 2021 end-page: 1212 ident: CR11 article-title: Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: A population-level observational study publication-title: Lancet doi: 10.1016/S0140-6736(21)00575-4 – volume: 386 start-page: 2201 issue: 23 year: 2022 end-page: 2212 ident: CR12 article-title: Protection and waning of natural and hybrid immunity to SARS-CoV-2 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2118946 – volume: 27 start-page: 1860.e7 issue: 12 year: 2021 end-page: 1860.e10 ident: CR8 article-title: Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients publication-title: Clin. Microbiol. Infect. doi: 10.1016/j.cmi.2021.07.030 – ident: CR15 – ident: CR2 – volume: 42 start-page: 85 year: 2022 end-page: 96 ident: CR1 article-title: Antibody dynamics and durability in coronavirus disease-19 publication-title: Clin. Lab. Med. doi: 10.1016/j.cll.2021.10.004 – volume: 51 start-page: e13520 issue: 4 year: 2021 ident: CR9 article-title: SARS-CoV-2 re-infection risk in Austria publication-title: Eur. J. Clin. Investig. doi: 10.1111/eci.13520 – ident: CR13 – volume: 73 start-page: e1214 issue: 5 year: 2021 end-page: e1218 ident: CR7 article-title: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence and risk factors among oligo/asymptomatic healthcare workers: Estimating the impact of community transmission publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciaa1845 – volume: 25 start-page: 2000045 issue: 3 year: 2020 ident: CR14 article-title: Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. [Published correction appears in Euro Surveill. 2021 Feb;26(5)] publication-title: Euro Surveill. doi: 10.2807/1560-7917.ES.2020.25.3.20000459- – volume: 8 start-page: 112911 issue: 209 year: 2022 ident: CR3 article-title: SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity publication-title: Environ. Res. doi: 10.1016/j.envres.2022.112911 – volume: 75 start-page: e201 issue: 1 year: 2022 end-page: e207 ident: CR4 article-title: Reinfection with severe acute respiratory syndrome coronavirus 2 among previously infected healthcare personnel and first responders publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciab952 – volume: 71 start-page: 549 issue: 15 year: 2022 end-page: 555 ident: CR5 article-title: Effectiveness of COVID-19 mRNA vaccination in preventing COVID-19-associated hospitalization among adults with previous SARS-CoV-2 infection—United States, June 2021–February 2022 publication-title: MMWR Morb. Mortal. Wkly. Rep. doi: 10.15585/mmwr.mm7115e2 – volume: 71 start-page: 549 issue: 15 year: 2022 ident: 25908_CR5 publication-title: MMWR Morb. Mortal. Wkly. Rep. doi: 10.15585/mmwr.mm7115e2 – volume: 397 start-page: 1204 issue: 10280 year: 2021 ident: 25908_CR11 publication-title: Lancet doi: 10.1016/S0140-6736(21)00575-4 – volume: 386 start-page: 2201 issue: 23 year: 2022 ident: 25908_CR12 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2118946 – volume: 8 start-page: 112911 issue: 209 year: 2022 ident: 25908_CR3 publication-title: Environ. Res. doi: 10.1016/j.envres.2022.112911 – volume: 397 start-page: 452 year: 2021 ident: 25908_CR6 publication-title: Lancet doi: 10.1016/S0140-6736(21)00183-5 – volume: 25 start-page: 2000045 issue: 3 year: 2020 ident: 25908_CR14 publication-title: Euro Surveill. doi: 10.2807/1560-7917.ES.2020.25.3.20000459- – ident: 25908_CR2 – volume: 75 start-page: e201 issue: 1 year: 2022 ident: 25908_CR4 publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciab952 – volume: 42 start-page: 85 year: 2022 ident: 25908_CR1 publication-title: Clin. Lab. Med. doi: 10.1016/j.cll.2021.10.004 – ident: 25908_CR13 – volume: 73 start-page: e1214 issue: 5 year: 2021 ident: 25908_CR7 publication-title: Clin. Infect. Dis. doi: 10.1093/cid/ciaa1845 – volume: 27 start-page: 1860.e7 issue: 12 year: 2021 ident: 25908_CR8 publication-title: Clin. Microbiol. Infect. doi: 10.1016/j.cmi.2021.07.030 – ident: 25908_CR15 – volume: 22 start-page: 821 issue: 6 year: 2022 ident: 25908_CR10 publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(22)00069-X – volume: 51 start-page: e13520 issue: 4 year: 2021 ident: 25908_CR9 publication-title: Eur. J. Clin. Investig. doi: 10.1111/eci.13520 |
| SSID | ssj0000529419 |
| Score | 2.5802438 |
| Snippet | In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated... In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We investigated... Abstract In this large cohort of healthcare workers, we aimed to estimate the rate of reinfections by SARS-CoV-2 over 2 years of the COVID-19 pandemic. We... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 712 |
| SubjectTerms | 631/326/2521 692/699/255/2514 Brazil - epidemiology Coronaviruses COVID-19 COVID-19 - epidemiology Health care Health Personnel Humanities and Social Sciences Humans Medical personnel multidisciplinary Pandemics Polymerase chain reaction Reinfection - epidemiology SARS-CoV-2 - genetics Science Science (multidisciplinary) Severe acute respiratory syndrome coronavirus 2 |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQVSQuiPIMtMhI3CBqbCd-HGmhgktBCFA5WX6qK0G22t0i9d_wW_hlzMTZ0OV54RqPpdF4nPnGHn9DyOOGO6WZy3WX8OhGy1B7H0SNpNjGqbYLzg_NJtTxsT45MW8utfrCmrBCD1wMt6-DYkhRkmJ0bcqNgYgUfQg6K-W5Tvj3bZS5lEwVVm9uWmbGVzKN0PtLiFT4mgxyL459vmu5EYkGwv7focxfiyV_ujEdAtHRDXJ9RJD0WdF8h1xJ_U1ytfSUvLhFPr5N6wKrniIPBJ311FFshLtY0Xmmp1PFF8WiLIB_FMs4Kf_29QLcfokygArp4esPr57XzNAzPGf-PAu3yfujF-8OX9Zj_4Q6AA5b1QmwSGQeArjXITQqC91l5oyTLCK1WWiS8qaJbVYu85wAKSJ3TgyZtyl2WdwhW_28T_cIlc5D3mESS1y0MrUmNExH2cpsoulSWxG2tqUNI7k49rj4ZIdLbqFtsb8F-9vB_lZW5Mk056xQa_xV-gCXaJJEWuzhAziLHZ3F_stZKrK7XmA77tWl5Up2kIQaYSryaBqGXYZXJ65P8_MiA3kIZF8VuVv8YdJEAGgDZ2MVURuesqHq5kg_Ox2YvI0WSnUw8-nap36o9WdT3P8fpnhArnHAa3iaxMQu2VotztMe2Q5fVrPl4uGwm74DiOwh-Q priority: 102 providerName: Directory of Open Access Journals |
| Title | Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic |
| URI | https://link.springer.com/article/10.1038/s41598-022-25908-6 https://www.ncbi.nlm.nih.gov/pubmed/36639411 https://www.proquest.com/docview/2765249939 https://www.proquest.com/docview/2765772597 https://pubmed.ncbi.nlm.nih.gov/PMC9837751 https://doaj.org/article/8c715096edda4ef09812dbcc8f77b28e |
| Volume | 13 |
| WOSCitedRecordID | wos000968670400015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M7P dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: 7X7 dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: BENPR dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: PIMPY dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M2P dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RLkhceJcGyspI3CBqnJftE6KlFT10WVWAllPk-EFXotlld4vUf8-Mk021PHrh4kPiSE5mJv7m4W8AXiWpFpJrHxeOQjeyNHFdmywmUmylRV4YXYdmE2I0kpOJGncBt2VXVrn-J4YftZ0ZipHvp6Is0FVQmXo7_xFT1yjKrnYtNLZggMiGU0nXaTruYyyUxcq56s7KJJncX-J-RWfK0ANLqdt3XG7sR4G2_29Y88-Syd_ypmE7Or7_vy_yAO51QJS9azXnIdxyzSO407amvHoMkzO3rtNqGNFJsGnDNKN-uosVm3l23heOMartQhTJqBqUpewKjWdJUxBbssOPX07ex1yxOUWrL6bmCXw-Pvp0-CHuujDEBtHcKnaIaCyvEQbU0phE-EwWnmulS26JIM0kTtQqsbkX2qfeId4kBh5rfJo7W_hsB7abWeN2gZW6Ru9FOe7SLC9drkzCpS3z0iurCpdHwNeyqExHUU6dMr5XIVWeyaqVX4Xyq4L8qjKC1_0z85ag48bZByTifiaRa4cLs8W3qrPVShrBiRXHWatz5xOFIMjWxkgvRJ1KF8HeWrJVZ_HL6lqsEbzsb6OtUgJGN2522c5BbwZ9uAietvrUryRD6IfKyiMQG5q2sdTNO830PPCBK5kJUeCTb9Y6eb2sf3-KZze_xXO4myKeo2gTz_Zge7W4dC_gtvm5mi4XQ9gSExFGOYTBwdFofDYM4YxhsEAaBY6D8cnp-OsvYNg0-g |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKAcGFfQkUMBKcIGrsLLYPCEFL1VHLUKGC5mYcL3QkyAwzU9D8KX4j72WrhqW3HrgmTmQn31v9_D1CniTcCMlMiHOPqRtZ2LgsbRojKbYyIsutKetmE2I4lKOROlgjP7uzMFhW2enEWlG7icUc-SYXRQ6hgkrVy-m3GLtG4e5q10KjgcWeX_6AkG3-YrAN__cp5ztvDrd247arQGzBO1nEHiy0YyWYtVJam4iQyjwwo0zBHBJ-2cSLUiUuC8IEHjz4T8go42zgmXd5SOG958j5DJnFsFSQH_Q5Hdw1y5hqz-Ykqdycg33EM2wQ8XHsLh4XK_avbhPwN9_2zxLN3_Zpa_O3c_V_-3DXyJXW0aavGsm4TtZ8dYNcbFpvLm-S0Xvf1aFVFOky6LiihmK_4NmCTgI96gvjKNaugZdMsdqVcrqExcxxCPjOdOvdx8F2zBSdYjb-69jeIh_OZFm3yXo1qfxdQgtTQnSmPPM8zQqfKZsw6YqsCMqp3GcRYd2_17alYMdOIF90XQqQSt3gRQNedI0XXUTkWf_MtCEgOXX0a4RUPxLJw-sLk9ln3eoiLa1gyPrjnTOZD4kCJ8-V1sogRMmlj8hGhyTdarS5PoFRRB73t0EX4QaTqfzkuBkD0RrEqBG50-C3n0kKri0IB4uIWEH2ylRX71Tjo5rvXMlUiByefN7JwMm0_v0p7p2-ikfk0u7h2329Pxju3SeXOfiumFlj6QZZX8yO_QNywX5fjOezh7WMU_LprGXjFxlhi7g |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lj9MwEB4tXUBceD8CCxgJThA1dh62DwjBlhXVQqkQrMopJI7NVoK0tF1Q_xq_jpm8VuWxtz1wTZzITr6Z-WY8ngF4GIhMKp45P7YUulGJ8fPchD4VxdaZjGKT5VWzCTkaqclEj7fgZ3sWhtIqW51YKepiZihG3hcyidFV0KHuuyYtYjzYezb_5lMHKdppbdtp1BDZt-sf6L4tnw4H-K8fCbH38v3uK7_pMOAbZCor36K1LniOJi5XxgTShSp2PNNZwgsq_mUCK3MdFJGTmRPOIpei6jKFcSKyRexCfO8Z2EZKHokebI-Hb8YfuwgP7aFFXDcndYJQ9ZdoLelEG_p_gnqN-8mGNayaBvyN6f6ZsPnbrm1lDPcu_c-f8TJcbCg4e17LzBXYsuVVOFc35Vxfg8k722aolYwKabBpyTJGnYQXKzZz7LBLmWOU1Yb8mVEeLBNsjYtZ0hBk1Wz37cFw4HPN5hSn_zo11-HDqSzrBvTKWWlvAUuyHEGiLbcijBIbaRNwVSRR4nShYxt5wFscpKYpzk49Qr6kVZJAqNIaOyliJ62wkyYePO6emdelSU4c_YLg1Y2ksuLVhdnic9poqVQZyakekC2KLLIu0Ej_itwY5aTMhbIe7LSoShtdt0yPIeXBg-42ainaespKOzuqx6Afh96rBzdrLHczCZH0oqBwD-QGyjemunmnnB5WldC1CqWM8cknrTwcT-vfn-L2yau4D-dRJNLXw9H-HbggkNRSyI2HO9BbLY7sXThrvq-my8W9RuAZfDpt4fgFYK-WAQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reinfection+rate+in+a+cohort+of+healthcare+workers+over+2%C2%A0years+of+the+COVID-19+pandemic&rft.jtitle=Scientific+reports&rft.au=Guedes%2C+Ana+Rubia&rft.au=Oliveira%2C+Maura+S.&rft.au=Tavares%2C+Bruno+M.&rft.au=Luna-Muschi%2C+Alessandra&rft.date=2023-01-13&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-022-25908-6&rft.externalDocID=10_1038_s41598_022_25908_6 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |